# Real-World Observational Study to Describe Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer in East Asia

> **NCT05606094** · — · COMPLETED · sponsor: **Daiichi Sankyo Co., Ltd.** · enrollment: 450 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05606094
- **Lead sponsor:** Daiichi Sankyo Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-09
- **Primary completion:** 2023-11-30
- **Final completion:** 2023-11-30
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2023-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05606094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05606094, "Real-World Observational Study to Describe Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer in East Asia". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05606094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*